Sign in

CIK 0001130598

  • Non-accelerated filer
  • Smaller reporting company

Traws Pharma, Inc.

Sign in to watch
Ticker
TRAW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 267-759-3680
Business address
12 PENNS TRAIL, NEWTOWN, PA, 18940
Former names
Onconova Therapeutics, Inc., ONCONOVA THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 26 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-06-29 GROOPMAN JEROME Director Exercise or conversion · Stock Option (right to buy) −10 990
2016-06-27 MARINO JAMES J Director Exercise or conversion +10 $5.20 $52 10
2016-06-27 MARINO JAMES J Director Exercise or conversion · Stock Option (right to buy) −10 990
2016-06-24 Fruchtman Steven M Chief Medical Officer Exercise or conversion +100 $6.50 $650 100
2016-06-24 Fruchtman Steven M Chief Medical Officer Exercise or conversion · Stock Option (right to buy) −100 12,411
2016-05-18 STOVER JACK E Director Grant or award · Stock Option (right to purchase) +10,000 10,000
2016-05-18 STOVER JACK E Director Grant or award · Stock Option (right to purchase) +20,000 20,000
2016-05-18 MEHTA VIREN Director Grant or award · Stock Option (right to purchase) +10,000 10,000
2016-05-18 Bienen Henry S Director Grant or award · Stock Option (right to purchase) +10,000 10,000
2016-05-18 Reddy E Premkumar Director Grant or award · Stock Option (right to purchase) +10,000 10,000
2016-05-18 GROOPMAN JEROME Director Grant or award · Stock Option (right to purchase) +10,000 10,000
2016-05-18 MARINO JAMES J Director Grant or award · Stock Option (right to purchase) +10,000 10,000
2016-05-18 Hoffman Michael B Director Grant or award · Stock Option (right to purchase) +13,000 13,000
2016-01-26 BANSAL AJAY Chief Financial Officer Grant or award · Stock Option (right to purchase) +69,984 69,984
2016-01-26 Fruchtman Steven M Chief Medical Officer Grant or award · Stock Option (right to purchase) +125,107 125,107
2016-01-26 Kumar Ramesh President and CEO Grant or award · Stock Option (right to buy) +146,440 146,440
2016-01-26 MCKEARN THOMAS J President, R&D Grant or award · Stock Option (right to purchase) +71,029 71,029
2016-01-26 Maniar Manoj SVP - Product Development Grant or award · Stock Option (right to purchase) +103,918 103,918
2016-01-26 Guerin Mark Patrick Chief Accounting Officer Grant or award · Stock Option (right to purchase) +46,809 46,809
2015-09-25 Kumar Ramesh President and CEO Grant or award · Stock Option (right to purchase) +87,500 87,500

Page 19 of 23 · 449 trades